Their concentration differences were statistically significant in comparison to patients with simple steatosis (IL-4 and IL-17) or to both groups of noncirrhosis NAFLD (IFNγ) (Figure 1). The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatotic liver disease.